Cargando…
CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498453/ https://www.ncbi.nlm.nih.gov/pubmed/25578475 http://dx.doi.org/10.1038/leu.2015.10 |
| _version_ | 1782380626156978176 |
|---|---|
| author | Gregory, G P Hogg, S J Kats, L M Vidacs, E Baker, A J Gilan, O Lefebure, M Martin, B P Dawson, M A Johnstone, R W Shortt, J |
| author_facet | Gregory, G P Hogg, S J Kats, L M Vidacs, E Baker, A J Gilan, O Lefebure, M Martin, B P Dawson, M A Johnstone, R W Shortt, J |
| author_sort | Gregory, G P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4498453 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44984532015-07-21 CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo Gregory, G P Hogg, S J Kats, L M Vidacs, E Baker, A J Gilan, O Lefebure, M Martin, B P Dawson, M A Johnstone, R W Shortt, J Leukemia Letter to the Editor Nature Publishing Group 2015-06 2015-02-03 /pmc/articles/PMC4498453/ /pubmed/25578475 http://dx.doi.org/10.1038/leu.2015.10 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Letter to the Editor Gregory, G P Hogg, S J Kats, L M Vidacs, E Baker, A J Gilan, O Lefebure, M Martin, B P Dawson, M A Johnstone, R W Shortt, J CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo |
| title | CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo |
| title_full | CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo |
| title_fullStr | CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo |
| title_full_unstemmed | CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo |
| title_short | CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo |
| title_sort | cdk9 inhibition by dinaciclib potently suppresses mcl-1 to induce durable apoptotic responses in aggressive myc-driven b-cell lymphoma in vivo |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498453/ https://www.ncbi.nlm.nih.gov/pubmed/25578475 http://dx.doi.org/10.1038/leu.2015.10 |
| work_keys_str_mv | AT gregorygp cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT hoggsj cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT katslm cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT vidacse cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT bakeraj cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT gilano cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT lefeburem cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT martinbp cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT dawsonma cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT johnstonerw cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo AT shorttj cdk9inhibitionbydinaciclibpotentlysuppressesmcl1toinducedurableapoptoticresponsesinaggressivemycdrivenbcelllymphomainvivo |